Literature DB >> 8831858

Prevalence of depression among patients seen in community health centres and community mental health centres.

R K Salokangas1, O Poutanen, E Stengård, R Jähi, T Palo-oja.   

Abstract

Depression is a common disorder in the general population. However, its prevalence among patients attending various health-care facilities is less well known. There have been very few Finnish studies of this topic. The Tampere Depression Project (TADEP) dealt with the prevalence of depression and factors associated with it in individuals seen in community health centres (CHC) and in psychiatric-service (PS) patients. The diagnosis of depression was based on a standardized Present State Examination interview and a DSM-III-R assessment, carried out on 436 CHC patients and 428 PS patients. The severity of depression was assessed using the Hamilton Rating Scale of Depression. About 10% of CHC patients and 50% of PS patients suffered from clinical depression. In addition to these, some depressive symptoms were displayed by just under 10% of subjects. Similar prevalence rates were obtained by the various methods used. The 1-year prevalence rate of clinical depression was 20% for the CHC patients and almost 60% for the PS patients. Mild depression represented the largest group. In the CHC group, depression was found more often in middle-aged and widowed subjects and in patients with a lower educational level and blue-collar workers than in others. In the PS group, depression was found more often in women, the oldest subjects and the widowed than in others.

Entities:  

Mesh:

Year:  1996        PMID: 8831858     DOI: 10.1111/j.1600-0447.1996.tb10673.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study.

Authors:  U F Malt; O H Robak; H P Madsbu; O Bakke; M Loeb
Journal:  BMJ       Date:  1999-05-01

2.  Identification of major depressive disorder among the long-term unemployed.

Authors:  Kirsti Nurmela; Aino Mattila; Virpi Heikkinen; Jukka Uitti; Aarne Ylinen; Pekka Virtanen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-09       Impact factor: 4.328

3.  Noncancer life stresses in newly diagnosed cancer.

Authors:  Ulla-Sisko Lehto; Markku Ojanen; Anna Väkevä; Arpo Aromaa; Pirkko Kellokumpu-Lehtinen
Journal:  Support Care Cancer       Date:  2008-04-02       Impact factor: 3.603

4.  Multiple depression : making mood manageable.

Authors:  Ilpo Helén
Journal:  J Med Humanit       Date:  2007-09

5.  Baseline psychosocial predictors of survival in localised breast cancer.

Authors:  U-S Lehto; M Ojanen; T Dyba; A Aromaa; P Kellokumpu-Lehtinen
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

6.  Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer.

Authors:  Ulla-Sisko Lehto; Markku Ojanen; Anna Väkevä; Tadeusz Dyba; Arpo Aromaa; Pirkko Kellokumpu-Lehtinen
Journal:  Qual Life Res       Date:  2018-12-03       Impact factor: 4.147

7.  Differential Effects of Sleep Disturbance and Malnutrition on Late-Life Depression Among Community-Dwelling Older Adults.

Authors:  Gyubeom Hwang; Yong Hyuk Cho; Eun Jwoo Kim; Ji Won Woang; Chang Hyung Hong; Hyun Woong Roh; Sang Joon Son
Journal:  Front Psychiatry       Date:  2022-05-06       Impact factor: 4.157

8.  Patients with depressive disorder, their co-morbidity, visiting rate and disability in relation to self-evaluation of physical and mental health: a cross-sectional study in family practice.

Authors:  Kadri Suija; Ruth Kalda; Heidi-Ingrid Maaroos
Journal:  BMC Fam Pract       Date:  2009-06-01       Impact factor: 2.497

9.  Screening and diagnosing depression in women visiting GPs' drop in clinic in Primary Health Care.

Authors:  Ranja Stromberg; Estera Wernering; Anna Aberg-Wistedt; Anna-Karin Furhoff; Sven-Erik Johansson; Lars G Backlund
Journal:  BMC Fam Pract       Date:  2008-06-13       Impact factor: 2.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.